Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Provigil modafinil: Phase II data; marketed to treat excessive daytime sleepiness in narcolepsy

In a 4-week, double-blind U.S. Phase II study in 48 children

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE